Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Y7UG
|
||||
Former ID |
DNC013579
|
||||
Drug Name |
N,N'-(1',6-hexylene)-bis-(-)-nor-MEP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529368] | ||
Structure |
Download2D MOL |
||||
Formula |
C34H52N2O2
|
||||
Canonical SMILES |
CCC1(CCCCN(C1)CCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC<br />(=CC=C4)O
|
||||
InChI |
1S/C34H52N2O2/c1-3-33(29-15-13-17-31(37)25-29)19-7-11-23-35(27-33)21-9-5-6-10-22-36-24-12-8-20-34(4-2,28-36)30-16-14-18-32(38)26-30/h13-18,25-26,37-38H,3-12,19-24,27-28H2,1-2H3/t33-,34-/m1/s1
|
||||
InChIKey |
YBOHCXLIWATJCJ-KKLWWLSJSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [529368] | |
Acetylcholinesterase | Target Info | Inhibitor | [529368] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.